TEZSPIRE® (tezepelumab-ekko)

TEZSPIRE® (tezepelumab-ekko) is an add-on maintenance treatment for people 12 and up with severe asthma. It’s not used to treat sudden breathing problems. May cause allergic reactions. Get help right away if you have a rash, trouble breathing, hives, or itchy and swollen eyes. Don’t stop your asthma treatments. Tell your doctor if your asthma worsens or you have a parasitic infection. Avoid live vaccines. Sore throat, joint, and back pain may occur.

We encourage you to watch, share, and learn with others.

This content is for informational purposes only and is not intended to be a substitute for medical advice.

You may report side effects related to AstraZeneca products by clicking here: http://us-aereporting.astrazeneca.com/

Please see the links below or visit TEZSPIRE.com for full Important Safety Information and Prescribing Information.

TEZSPIRE is a registered trademark of Amgen Inc. and AstraZeneca.
©2022 AstraZeneca. All rights reserved.
US-68755 Last Updated 10/22